In conclusion, we report that caveolin-1 plays an immensely important role in radio-resistance and cancer progression in lung adenocarcinoma, and caveolin-1 has the potential to be used as prognostic biomarker for radiation treatment response and tumor aggression in clinical setting for precision medicine. This evidence concerns the gene CAV1 and cancer.